Randomized phase II study of vorinostat or placebo in combination with carboplatin and paclitaxel for patients with advanced or metastatic non-small cell lung cancer.

Trial Profile

Randomized phase II study of vorinostat or placebo in combination with carboplatin and paclitaxel for patients with advanced or metastatic non-small cell lung cancer.

Completed
Phase of Trial: Phase II

Latest Information Update: 19 Dec 2012

At a glance

  • Drugs Vorinostat (Primary) ; Carboplatin; Paclitaxel
  • Indications Non-small cell lung cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 26 Apr 2011 New source identified and integrated (University of Southern California Norris Comprehensive Cancer Center; 2N10-3).
    • 23 Nov 2009 Results published in the Journal of Clinical Oncology.
    • 04 Aug 2009 Interim results presented at the 13th World Conference on Lung Cancer
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top